Atlas Trials

Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia

Clinical trial NCT00759460 · COMPLETED

Trial details

NCT number
NCT00759460
Sponsor
H. Lundbeck A/S
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2007-03-01
Primary completion
2008-03-01
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.